8.2 Cost-effectiveness and health economic implications The elevated cost of acquisition of GLP-1 receptor agonists convey major challenges for healthcare systems, with yearly treatment expenses between $10,000 and $15,000 USD, markedly surpassing those of conventional diabetic drugs (Kong et al
This explains why many slim, fit women still have a noticeable shelf
Between 2019 and 2024, prescriptions for GLP-1 drugs rose 587%
Anne Critchlow, analyst at Berenberg bank, suggests there is no coincidence in the shift from the baggy and boxy fashion shapes of the Covid and post-pandemic years when weight gain due to lockdown was a common theme towards a more body-conscious, nipped-in, structured silhouette.Berenberg analysts estimate a 1% boost to the overall UK clothing market from GLP-1s in each of the next three years
Current research focuses on enhancing transdermal absorption through various technologies including microneedle patches, chemical penetration enhancers, and modified drug formulations